First Allied Advisory Services’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,827
Closed -$345K 1257
2018
Q2
$345K Buy
+6,827
New +$271K 0.01% 827

Other funds holding GHDX

First Allied Advisory Services's GHDX Position: Q3 2018 in Review

First Allied Advisory Services sold out of Genomic Health, Inc. (GHDX) in Q3 2018, closing a stake of 6,827 shares — an estimated $345K sold.

First Allied Advisory Services first reported a position in GHDX in Q2 2018 and held it in 1 quarter. The position peaked at $345K in Q2 2018. 201 funds tracked by Wall St. Rank hold GHDX as of Q3 2018.

  • First Allied Advisory Services reported no remaining Genomic Health, Inc. position as of Q3 2018 after selling out during the quarter.
  • First Allied Advisory Services sold 6,827 Genomic Health, Inc. shares in Q3 2018, an estimated $345K.
  • First Allied Advisory Services first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 1 quarter.
  • First Allied Advisory Services's Genomic Health, Inc. position peaked at $345K in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2018.

Based on First Allied Advisory Services's 13F filing for Q3 2018, filed 14 Nov 2018.